BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gabizon A, Shmeeda H, Tahover E, Kornev G, Patil Y, Amitay Y, Ohana P, Sapir E, Zalipsky S. Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside. Advanced Drug Delivery Reviews 2020;154-155:13-26. [DOI: 10.1016/j.addr.2020.07.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhu L, Kuang Z, Song P, Li W, Gui L, Yang K, Ge F, Tao Y, Zhang W. Gold nanorod-loaded thermosensitive liposomes facilitate the targeted release of ruthenium(II) polypyridyl complexes with anti-tumor activity. Nanotechnology 2021;32. [PMID: 34352731 DOI: 10.1088/1361-6528/ac1afc] [Reference Citation Analysis]
2 Mohan CD, Rangappa S, Nayak SC, Jadimurthy R, Wang L, Sethi G, Garg M, Rangappa KS. Bacteria as a treasure house of secondary metabolites with anticancer potential. Semin Cancer Biol 2021:S1044-579X(21)00134-6. [PMID: 33979675 DOI: 10.1016/j.semcancer.2021.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Qi L, Liu C, Zhang Y, Zhang Z, Duan H, Zhao H, Xin X, Chen L, Jin M, Guan Y, Gao Z, Huang W. Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π-π Stacking and Its Therapeutic Application in Bladder Cancer. Pharmaceutics 2021;13:1776. [PMID: 34834192 DOI: 10.3390/pharmaceutics13111776] [Reference Citation Analysis]
4 Gyanani V, Haley JC, Goswami R. Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems. Pharmaceuticals (Basel) 2021;14:835. [PMID: 34577537 DOI: 10.3390/ph14090835] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Han X, Sun M, Chen B, Saiding Q, Zhang J, Song H, Deng L, Wang P, Gong W, Cui W. Lotus seedpod-inspired internal vascularized 3D printed scaffold for bone tissue repair. Bioact Mater 2021;6:1639-52. [PMID: 33313444 DOI: 10.1016/j.bioactmat.2020.11.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Bao S, Zheng H, Ye J, Huang H, Zhou B, Yao Q, Lin G, Zhang H, Kou L, Chen R. Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment. Front Pharmacol 2021;12:625084. [PMID: 33815107 DOI: 10.3389/fphar.2021.625084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]